Bio-Techne TECH
NASDAQ TECH
$72.83 +0.05 (+0.07%)
At close: Nov 9, 2026 · 4:00 PM EST

Bio-Techne (TECH) Gains (Losses) on Sale of Assets & Investments (2014 - 2023)

Updated

Bio-Techne's Non Operating Investment Income was -$5.86 million in FY2026 (year ended Jun 30, 2026).

Analysis

Bio-Techne (TECH) Gains (Losses) on Sale of Assets & Investments (2014 - 2023) Analysis & Trends

From FY2021 onward, Bio-Techne has reported Non Operating Investment Income for 5 fiscal years.

  • The FY2026 figure marks the lowest annual Non Operating Investment Income since FY2021.
  • Per Business Quant data, Non Operating Investment Income in earlier fiscal years was $283,000 in FY2024 (-99.4%), $49.33 million in FY2023 (+224.8%) and $15.19 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Thermo Fisher Scientific 267.71 Bn 244.23 Bn 5.13 Bn -
2 Abbott Laboratories 191.69 Bn 165.56 Bn 7.39 Bn -
3 Danaher 166.18 Bn 145.83 Bn 3.84 Bn -
4 Intuitive Surgical 161.07 Bn 141.36 Bn 2.08 Bn -
5 Medtronic 131.65 Bn 96.90 Bn 6.34 Bn -
6 Stryker 125.25 Bn 111.44 Bn 4.25 Bn -
7 Boston Scientific 63.85 Bn 59.29 Bn 3.43 Bn -
8 Edwards Lifesciences 60.52 Bn 43.72 Bn 1.35 Bn -
9 Becton Dickinson 59.08 Bn 56.23 Bn 2.32 Bn -
10 Bio-Techne 11.36 Bn 10.57 Bn 211.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 283,000.00
Jun 30, 2023 -681,000.00
Mar 31, 2023 314,000.00
Dec 31, 2022 -74,000.00
Sep 30, 2022 49.77 Mn
Dec 31, 2014 8.30 Mn
API Access

Bio-Techne Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=TECH&period=max&api_key=YOUR_API_KEY